Ryu S, Ahn YJ, Yoon C, Chang JH, Park Y, Kim TH, Howland AR, Armstrong CA, Song PI, Moon AR. The regulation of combined treatment-induced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells. BMC Cancer. 2018 Apr 16;18(1):432. PubMed PMID: 29661248
Ryu S, Youn C, Moon AR, Howland A, Armstrong CA, Song PI. Therapeutic Inhibitors against Mutated BRAF and MEK for the Treatment of Metastatic Melanoma. Chonnam Med J. 2017 Sep;53(3):173-177. PubMed PMID: 29026704
Ryu S, Broussard L, Youn C, Song B, Norris D, Armstrong CA, Kim B, Song PI. Therapeutic Effects of Synthetic Antimicrobial Peptides, TRAIL and NRP1 Blocking Peptides in Psoriatic Keratinocytes. Chonnam Med J. 2019 May;55(2):75-85. PubMed PMID: 31161119
Song PI, Armstrong CA. Novel therapeutic approach with PAC-14028 cream, a TRPV1 antagonist, for patients with mild-to-moderate atopic dermatitis. Br J Dermatol. 2019 May;180(5):971-972. PubMed PMID: 31025744
Armstrong CA: Approach to the clinical dermatologic diagnosis. Dellavalle RP (section editor), Corona R (deputy editor). 2022. UpToDate, Inc.
Brice SL, Armstrong CA: Viral diseases of the skin. Conn's Current Therapy, 2023, in press 2022